Signalling Pathways in Metabolic Diseases and Cancers
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Biochemistry".
Deadline for manuscript submissions: 15 November 2024
Special Issue Editor
Interests: molecular biology; cancer; cell line; cell culture; flow cytometry analysis; Western blotting; gene expression; sequencing; proteomics; seminoma cell line; prostate cancer cell lines
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cellular signaling pathways play a crucial role in cellular communication and adaptation to the everchanging surrounding environment, ultimately governing key fate decisions such as cell death, survival, division, or senescence. Cellular signaling processes are elicited by a variety of extracellular and intracellular inducers, such as growth factors, nutrients, or stress and damage stimuli. Likewise, the transmission of information on activated signaling pathways can rely on a plethora of signaling mediators. Moreover, many of these pathways are connected to form signaling networks to ensure the right timing and termination of cell responses. Notably, the dysregulation of signaling pathways has been implicated in the pathogenesis of several diseases, including cancer, inflammation, and metabolic disorders.
We therefore welcome original papers that report novel research findings and results on different aspects of cellular signaling, with special attention paid to novel regulators of pro-survival/pro-apoptotic signaling cascades; advances in targeted therapeutic strategies to manipulate signaling cascades, such as immunological therapies and so on; and the investigation of dysregulated molecular mechanisms underlying several metabolic and immunological diseases and tumors
This Special Issue is supervised by Dr. Bossio and assisted by Dr. Gallo and Dr. Palummo.
Dr. Sabrina Bossio
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- prostate cancer
- molecular signalling pathway
- metabolic diseases
- diabets
- immunotherapy
- immunological diseases
